RxDoctor Payments Data

William Landphair, DO

Pain Medicine · Chicago, ILNPI 1467742577

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 221 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Abbott accounts for 73.0% of it on its own, with 15 other manufacturers making up the rest. Reporting peaked in 2021 at $2,767 and has fallen 93.0% since, to $193 in 2025.

$11,974in general payments, 2019–2025

Across 221 payments — averaging $54.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$9K
  • Boston Scientific$553
  • Nalu Medical, Inc.$443
  • Flowonix Medical Incorporated$395
  • Relievant Medsystems, Inc.$321
  • Vertiflex, Inc.$312
  • plus $1K from 10 others

What the payments were for

  • Food & beverage$11,974100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$11,974 in reported general payments places this provider in the 80th percentile of 233 pain medicine providers in Illinois.

See all pain medicine providers in Illinois

Medicare billing

Part B allowed, 2024
$78,725
Medicare patients
179
Services billed
828

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen489$7,647
Pregabalin384$4,993
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen145$4,053
Gabapentin219$2,887
Naloxone Hcl31$2,199
Tizanidine Hcl95$1,631
Cyclobenzaprine Hcl106$1,117
Morphine Sulfate ErMorphine Sulfate28$902
Methocarbamol100$891
Oxycodone Hcl51$780
Baclofen24$459
Acetaminophen-CodeineAcetaminophen With Codeine34$347
Duloxetine Hcl34$328
Hydromorphone Hcl12$261
Meloxicam85$256

Paid to pharmacies, not to this prescriber.

Other pain medicine in Chicago

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →